This inventor holds 1 USPTO granted patent. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Vadim M V Markovtsov: Innovator in Antiproliferative Compounds
Introduction
Vadim M V Markovtsov is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with antiproliferative activity.
Latest Patents
Markovtsov holds a patent for "Cycloalkyl substituted pyrimidinediamine compounds and their uses." This patent describes 2,4-pyrimidinediamine compounds that exhibit antiproliferative activity. The compounds are designed for use in compositions aimed at inhibiting cellular proliferation and treating proliferative diseases, including tumorigenic cancers.
Career Highlights
Markovtsov is currently associated with Rigel Pharmaceuticals, Incorporated, where he continues to advance his research and development efforts. His work focuses on innovative solutions for treating various diseases through the use of novel chemical compounds.
Collaborations
Throughout his career, Markovtsov has collaborated with esteemed colleagues, including David Carroll and Kin Tso. These partnerships have contributed to the advancement of his research and the successful development of new therapeutic compounds.
Conclusion
Vadim M V Markovtsov is a distinguished inventor whose work in antiproliferative compounds has the potential to impact cancer treatment significantly. His contributions to the field exemplify the importance of innovation in medical research.